Pentixapharm Holding AG

Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Release of the Home Member State according to Article 5 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Pentixapharm Holding AG: Dr. Dirk Pleimes, Allocation of 400 spin-off shares in Pentixapharm Holding AG due to the ownership of 400 shares in Eckert & Ziegler SE.

Pentixapharm Holding AG: Dr. Harald Hasselmann, Allocation of 2,200 spin-off shares in Pentixapharm Holding AG due to the ownership of 2,200 shares in Eckert & Ziegler SE.

Pentixapharm Holding AG: Dr. Hakim Bouterfa, Allocation of 3,800 spin-off shares in Pentixapharm Holding AG due to the ownership of 3,800 shares in Eckert & Ziegler SE.

Pentixapharm Holding AG: Jens Giltsch, Allocation of 761 spin-off shares in Pentixapharm Holding AG due to the ownership of 761 shares in Eckert & Ziegler SE.

Pentixapharm Holding AG: Dr. Andreas Eckert, Allocation of 4 spin-off shares in Pentixapharm Holding AG due to the ownership of 4 shares in Eckert & Ziegler SE.

Pentixapharm Holding AG: Eckert Wagniskapital und Frühphasenfinanzierung GmbH, Allocation of 6,596,680 spin-off shares in Pentixapharm Holding AG due to the ownership of 6,596,680 shares in …

Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Pentixapharm Holding AG Completes IPO in the Prime Standard of the Frankfurt Stock Exchange

Pentixapharm Holding AG: Placement Price Set at EUR 5.10 per Share, All 3.9 Million Offer Shares Placed

Pentixapharm Holding AG Sets Price Range for Planned IPO

Pentixapharm Holding AG, a Subsidiary of Eckert & Ziegler SE, Plans IPO on the Prime Standard of the Frankfurt Stock Exchange

Pentixapharm AG Receives Orphan Drug Designation for its Radiodiagnostic Tracer PentixaFor in Marginal Zone Lymphoma by the European Medicines Agency

Pentixapharm Acquires Target Discovery Business of Glycotope

Pentixapharm Announces Expansion of Supervisory Board with the Appointment of Distinguished Endocrinologist Marcus Quinkler